- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05667025
Comparison of the Effects of Cycling FES and Conservative Rehabilitation Therapy on Stroke Patients
Comparison of the Effects of Cycling Functional Electrical Stimulation and Conservative Rehabilitation Therapy on the Functional Status and Muscle Characteristics of Stroke Patients
Study Overview
Status
Conditions
Detailed Description
Stroke is the second leading cause of death worldwide and is a major contributor to disability. It is one of the developments related to bleeding as a result of occlusion of blood vessels in the brain with a clot or damage from the vessels.Loss of strength and motor coordination in the lower and upper extremities is the main cause of disability after stroke. Activities such as walking, standing, sitting and daily activities such as dressing, bathing and toilet are frequently affected and sensorimotor disorders are common.
Functional electrical stimulation (FES) is one of the methods used in treatment. FES provides muscle contraction and movement by electrical stimulation of motor neurons. It is applied by a controller through skin electrodes to induce contractions. The FES-evoked bike allows people with or without voluntary leg movement to pedal an exercise bike on a fixed system.
In this study, the investigators aimed to compare the treatment efficacy and changes in muscle characteristics of conservative treatment and cycling FES in stroke patients.
Demographic data of the patients and healthy volunteers will be recorded. Hemiplegic patients will be evaluated in terms of Barthel Index, Modified Ashworth Scale, Berg Balance Scale, Functional Ambulation Scale, Brunnstrom's Hemiplegia Recovery Stage, Fatigue Severity Scale, Fugl-Meyer Assessment, 6-Minute Walking Test, Muscle strength measurement, pennation angle and thickness measurement of the musculus rectus femoris muscle
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Serdar Kılınç
- Phone Number: 9050559113181
- Email: drserdarkilinc@hotmail.com
Study Locations
-
-
-
Bolu, Turkey, 14100
- Abant Izzet Baysal University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients must be between the ages of 21-85.
- The time elapsed after stroke must be between 3-60 months.
- Patients must have had cerebrovascular disease for the first time.
- Patients' Functional Ambulation Scale grade ≤ 4
- Patients must be able to sit unsupported for 30 minutes and walk 6 meters with support or device.
- Patients' mini mental test score ≥ 24
Exclusion Criteria:
- Patients with peripheral nerve injury in the lower extremity
- Patients with a pacemaker or a pacemaker.
- Patients with severe spasticity of the lower extremities
- Patients with a history of more than one cerebrovascular disease
- Patients with a history of lower extremity fractures in the last 6 months
- Patients diagnosed with Parkinson, Multiple Sclerosis
- Patients with unstable cardiac pathology
- Patients' mini mental test score ≤ 24
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Conservative Rehabilitation
|
Joint range of motion, strengthening, balance-coordination and stretching exercises included in the conservative physiotherapy program 5 days a week for a total of 6 weeks
|
Active Comparator: Cycling Functional Electrical Stimulation in addition to Conservative Rehabilitation
|
Joint range of motion, strengthening, balance-coordination and stretching exercises included in the conservative physiotherapy program 5 days a week for a total of 6 weeks
In addition to conservative treatment, cycling FES to the affected lower extremity for 20 minutes, 3 days a week for 4 weeks.
During the treatment, the patient will be seated on a chair and her feet will be fixed to the pedal with velcro tape, and the comfort during the treatment will be provided with calf supports.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Berg Balance Scale
Time Frame: Before Treatment
|
The BBS is used to objectively determine a patient's ability to balance safely during a predetermined set of tasks.
The scale comprises 14 items.
Each item receives a score ranging from 0 to 4, which is a five-point rank scale with 0 indicating the lowest level of functioning and 4 indicating the highest level of functioning
|
Before Treatment
|
Functional Ambulation Scale
Time Frame: Before Treatment
|
Functional Ambulation Scale is a 6-point functional walking test that evaluates ambulation ability and determines the amount of human support required by patients while walking, regardless of whether they use a personal assistive device.
A score of 0 indicates that the patient has a dysfunctional ambulation A score of 5 denotes independent ambulation on any surface.
|
Before Treatment
|
Brunnstrom Stages
Time Frame: Before Treatment
|
Brunnstrom stages is a scale used to assess motor recovery after a stroke, which is expressed using values between 1 and 6.
The higher the value on this scale, the higher would be the recovery.
|
Before Treatment
|
Berg Balance Scale
Time Frame: 6 Week After Treatment
|
The BBS is used to objectively determine a patient's ability to balance safely during a predetermined set of tasks.
The scale comprises 14 items.
Each item receives a score ranging from 0 to 4, which is a five-point rank scale with 0 indicating the lowest level of functioning and 4 indicating the highest level of functioning
|
6 Week After Treatment
|
Functional Ambulation Scale
Time Frame: 6 Week After Treatment
|
Functional Ambulation Scale is a 6-point functional walking test that evaluates ambulation ability and determines the amount of human support required by patients while walking, regardless of whether they use a personal assistive device.
A score of 0 indicates that the patient has a dysfunctional ambulation A score of 5 denotes independent ambulation on any surface.
|
6 Week After Treatment
|
Brunnstrom Stages
Time Frame: 6 Week After Treatment
|
Brunnstrom stages is a scale used to assess motor recovery after a stroke, which is expressed using values between 1 and 6.
The higher the value on this scale, the higher would be the recovery.
|
6 Week After Treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Barthel Index
Time Frame: Before Treatment
|
The Barthel index is used to assess activities of daily living.
It consists of 10 items: feeding, bathing, grooming, dressing, bowel, bladder, toilet use, transfers, mobility, stairs.
Scores range from 0-100.
A score of 100 represents complete independence, and a score of 0 represents complete dependence.
|
Before Treatment
|
Barthel Index
Time Frame: 6 Week After Treatment
|
The Barthel index is used to assess activities of daily living.
It consists of 10 items: feeding, bathing, grooming, dressing, bowel, bladder, toilet use, transfers, mobility, stairs.
Scores range from 0-100.
A score of 100 represents complete independence, and a score of 0 represents complete dependence.
|
6 Week After Treatment
|
Modified Ashworth Scale
Time Frame: Before Treatment
|
Spasticity in the shoulder will be evaluated according to the Modified Ashworth Scale (MAS).
The Modified Ashworth Scale is a 6-point scale.
Scores range from 0 to 4, where lower scores represent normal muscle tone and higher scores represent increased degree of spasticity.
|
Before Treatment
|
Modified Ashworth Scale
Time Frame: 6 Week After Treatment
|
Spasticity in the shoulder will be evaluated according to the Modified Ashworth Scale (MAS).
The Modified Ashworth Scale is a 6-point scale.
Scores range from 0 to 4, where lower scores represent normal muscle tone and higher scores represent increased degree of spasticity.
|
6 Week After Treatment
|
6 min walking test
Time Frame: Before Treatment
|
It is used to evaluate the functional capacity of patients.
The patient is asked to walk in a 30-meter corridor marked at 3-meter intervals.
At the end of the test, the distance walked by the patient is recorded in meters.
|
Before Treatment
|
6 min walking test
Time Frame: 6 Week After Treatment
|
It is used to evaluate the functional capacity of patients.
The patient is asked to walk in a 30-meter corridor marked at 3-meter intervals.
At the end of the test, the distance walked by the patient is recorded in meters.
|
6 Week After Treatment
|
Fatigue Severity Scale
Time Frame: Before Treatment
|
The scale consists of 9 questions that test the fatigue severity of the subjects in the last week.
It is scored from 1 to 7. The result is found by the arithmetic mean.
4 or more indicates severe fatigue.
|
Before Treatment
|
Fatigue Severity Scale
Time Frame: 6 Week After Treatment
|
The scale consists of 9 questions that test the fatigue severity of the subjects in the last week.
It is scored from 1 to 7. The result is found by the arithmetic mean.
4 or more indicates severe fatigue.
|
6 Week After Treatment
|
Rectus Femoris Muscle Thickness
Time Frame: Before Treatment
|
The linear probe of the ultrasound will be placed transversely at the midpoint of the distance between the trochanter major and the lateral space of the knee joint, and muscle thickness will be measured without applying pressure.
|
Before Treatment
|
Rectus Femoris Muscle Thickness
Time Frame: 6 Week After Treatment
|
The linear probe of the ultrasound will be placed transversely at the midpoint of the distance between the trochanter major and the lateral space of the knee joint, and muscle thickness will be measured without applying pressure.
|
6 Week After Treatment
|
Pennate angle
Time Frame: Before Treatment
|
Pennate angle can be defined as the angle of entry of muscle fibers into the aponeurosis.
At the point where the rectus femoris muscle thickness is measured, the investigators will turn the ultrasound probe horizontally and measure the pennate angle formed by 3 different muscle fibers with the bottom fascia by goniometry and record the arithmetic average of these measurements.
|
Before Treatment
|
Pennate angle
Time Frame: 6 Week After Treatment
|
Pennate angle can be defined as the angle of entry of muscle fibers into the aponeurosis.
At the point where the rectus femoris muscle thickness is measured, the investigators will turn the ultrasound probe horizontally and measure the pennate angle formed by 3 different muscle fibers with the bottom fascia by goniometry and record the arithmetic average of these measurements.
|
6 Week After Treatment
|
Muscle strength measurement:
Time Frame: Before Treatment
|
Knee extensor and flexor muscle strength will be measured with a North Coast hydraulic hand dynamometer.
During the measurements, the knee will be in 90 degrees flexion while the patient is in a sitting position, the dynamometer will be placed in front of the ankle and the patient will be asked to push the dynamometer with all his strength, 3 measurements will be made and the average will be recorded as isometric knee extensor muscle strength.
In the same way, the dynamometer will be placed behind the ankle and the patient will be asked to push the dynamometer with all his strength, the average of the 3 measurements will be taken and recorded as isometric knee flexor muscle strength.
|
Before Treatment
|
Muscle strength measurement:
Time Frame: 6 Week After Treatment
|
Knee extensor and flexor muscle strength will be measured with a North Coast hydraulic hand dynamometer.
During the measurements, the knee will be in 90 degrees flexion while the patient is in a sitting position, the dynamometer will be placed in front of the ankle and the patient will be asked to push the dynamometer with all his strength, 3 measurements will be made and the average will be recorded as isometric knee extensor muscle strength.
In the same way, the dynamometer will be placed behind the ankle and the patient will be asked to push the dynamometer with all his strength, the average of the 3 measurements will be taken and recorded as isometric knee flexor muscle strength.
|
6 Week After Treatment
|
Fugl-Meyer Assessment for lower extremity
Time Frame: Before Treatment
|
In the lower extremity motor subscale, reflex activity in supine and sitting positions, flexor synergy in supine position, extensor synergy in side-lying position, combined synergies in sitting, non-synergy movements in standing, normal reflexes in sitting position are examined.
Each item is scored with a 3-point ordinal scale (0: unable at all, 1: partially able, 2: fully able).
The maximum score is 28.
|
Before Treatment
|
Fugl-Meyer Assessment for lower extremity
Time Frame: 6 Week After Treatment
|
In the lower extremity motor subscale, reflex activity in supine and sitting positions, flexor synergy in supine position, extensor synergy in side-lying position, combined synergies in sitting, non-synergy movements in standing, normal reflexes in sitting position are examined.
Each item is scored with a 3-point ordinal scale (0: unable at all, 1: partially able, 2: fully able).
The maximum score is 28.
|
6 Week After Treatment
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Serdar Kılınç, Abant Izzet Baysal University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AIBU-FTR-SK-05
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hemiplegia
-
University of SalamancaCompleted
-
University Hospital, Clermont-FerrandUniversité d'AuvergneCompletedInfantile HemiplegiaFrance
-
Konya Beyhekim Training and Research HospitalNot yet recruiting
-
Hospices Civils de LyonRecruitingAlternating HemiplegiaFrance
-
Hospices Civils de LyonCompletedAlternating HemiplegiaFrance
-
University of Castilla-La ManchaCompleted
-
University Hospital of Mont-GodinneUniversité Catholique de LouvainUnknownBimanual Training in Children With Hemiplegia With Lower Limb and Postural Stimulation (HABIT & Leg)Congenital HemiplegiaBelgium
-
CEU San Pablo UniversityRecruiting
-
University of UtahJazz Pharmaceuticals; Alternating Hemiplegia of Childhood FoundationCompletedAlternating Hemiplegia of ChildhoodUnited States
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingAlternating Hemiplegia of ChildhoodFrance
Clinical Trials on Conservative rehabilitation
-
Universidad San JorgeAalborg UniversityCompletedHealthy | Neck Pain | Whiplash Injury | WhiplashSpain
-
Tampere University HospitalPihlajalinna Hospital, TampereNot yet recruitingRehabilitation | Patella Alta | Tibial Tubercle Distalisation Osteotomy
-
Abant Izzet Baysal UniversityCompleted
-
Riphah International UniversityCompleted
-
Istanbul University - Cerrahpasa (IUC)CompletedRotator Cuff InjuriesTurkey
-
University of OxfordUnknownAnterior Cruciate Ligament InjuryUnited Kingdom
-
University of HelsinkiActive, not recruitingSubacromial Impingement SyndromeFinland
-
Chang Gung Memorial HospitalUnknownPeripheral Arterial DiseaseTaiwan
-
The Hospital of VestfoldOslo University HospitalActive, not recruitingHypertension | Obstructive Sleep Apnea | Morbid Obesity | Osteoarthrosis | Type 2 DMNorway
-
University Hospital, ToursCompletedGenital Diseases, Female | Uterine Prolapse | Dysfunctional Uterine Bleeding | Cervical Dysplasia | Hysterotomy; Affecting Fetus | Leiomyomata Uteri | Adenomyosis, EndometriosisFrance